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Abstract The sugar moiety of IgA is known to provide a
link between the innate and adaptive immune systems.
Terminally located glycotopes on IgA are potential ligands
engaged in the interactions which may modulate the biolog-
ical activities of IgA. In the present work the expressions of
Maackia amurensis (MAA), Sambucus nigra (SNA), Lens
culinaris (LCA), Tetragonolobus purpureus (LTA), and
Ulex europaeus (UEA) reactive glycotopes on maternal
plasma and amniotic IgA were evaluated in relation to the
progression of a normal human pregnancy, from the 2nd
trimester, throughout the 3rd trimester, perinatal period,
post-date pregnancy and delivery, by lectin-IgA-ELISA,
using specific biotinylated lectins. The amniotic and mater-
nal plasma IgA concentrations and a degree of SNA and
LCA reactivity of maternal plasma IgA were almost unal-
tered during the normal pregnancy. The amniotic IgA from
the 2nd trimester was decorated by MAA-, SNA-reactive
and LCA-, LTA-, and UEA-reactive glycotopes. At the turn
of the 2nd and 3rd trimesters the expression of MAA-, SNA-,
LTA-, and UEA-reactive glycotopes, except for LCA-reactive,
increased and remained almost at unaltered levels throughout
the perinatal period and delivery. However, in the post-date
pregnancy the expression of LCA-, LTA-, and UEA-reactive
and SNA-reactive glycotopes were significantly higher. The
unique fucosylated and sialylated glycovariants of amniotic
IgA associated with the progression of the normal pregnancy
may illustrate a general importance of carbohydrate-lectin
receptor interactions in the control and modulation of biolog-
ical events to ensuring homeostasis during pregnancy, protec-
tion and well-being of fetus.
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LCA Lens culinaris lectin
LTA Tetragonolobus purpureus lectin
MAA Maackia amurensis lectin
SNA Sambucus nigra lectin




In the biological development processes the defined oligo-
saccharide structures appear in specific spatial and temporal
patterns [1]. During pregnancy, when intensive growth and
development of the fetus occur, glycans terminated with
sialic acid and/or fucose are known to control and modulate
biological reactions involved in cell-cell signaling, adhe-
sion, and stimulate cell growth and differentiation [2–4].
Additionally, the glycoconjugates bearing sialyl-Lewis anti-
gens participate in the prevention of leucocyte adhesion to
the fetal syncytiotrophoblast [5], and can interact with
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amniotic selectins and play an immunomodulatory role in
the late pregnancy [4, 6].
The glycosylation process during the pregnancy is stimu-
lated and controlled by the endocrine changes [7], different
sets and ratios of glycosyltransferases produced and activated
in many clones of B-cells [8], as well as cytokines (IL-6) [7,
9]. Some glycoproteins of amniotic fluid, such as glycodelin,
transferrin [10], human chorionic gonadotropin [11], α1-acid
glycoprotein [12], fibronectin [13] and IgG [14], represent
different schemes of glycosylation, particulary fucosylation
and sialylation, in comparison with the glycoproteins of the
maternal serum [4]. Moreover, glycosylation patterns of am-
niotic glycoproteins are reported to change throughout gesta-
tion because of different sites of biosynthesis (maternal, fetal,
and placental) at subsequent stages of pregnancy [4, 15, 16].
In human amniotic fluid IgA is much less abundant than
IgG. It can originate from maternal, fetal and placental
tissues. The share of IgA in amniotic fluid derived from
different sites of synthesis (local production in the decidua
as well as by fetal mucosa), and forms of its transport (a
nonspecific diffusion and receptor-mediated transport of
maternal IgA) is known to vary with gestational age [17,
18]. The maternal IgA, like IgG, is potentially available to
the embryo as early as on the 6th week of gestation [19].
The placental transfer of IgA starts when the first placental
villi are formed and increases as gestation advances [19]. In
contrast to IgG, amniotic IgA of fetal origin is more in favor
of a preimmune role by natural polyreactive IgA antibodies
similar to that reported for secretion [20]. Moreover, IgA in
amniotic fluid is involved in the protection of the fetus against
maternal IgG autoantibodies [21]. According to Quan et al.
[18] the amniotic immunoglobulins, both IgG and IgA, can
serve as a protection against pathogens and act through mech-
anisms similar to those observed in the female genital fluid.
The amniotic pool of IgA, similarly to the serum IgA [22],
consists mainly of monomeric form with a low level of secre-
tory IgA (SIgA), and with various amounts of free secretory
component (SC) [18]. Additionally, an unusual form of fetal
immunoglobulins, absent in the maternal serum, was ob-
served. This molecule contains no α chain but includes a
Fabγ fragment non-covalently associated with SC and can
act as an immune barrier against the infection and against
autoantibodies derived from the mother [18].
Immunoglobulins A, besides their high molecular hetero-
geneity related to the fact that they can exist as monomers,
dimers and oligomers, and additionally in IgA1and IgA2
subclasses, and as a SIgA, occur in diverse glycoforms with
the attached N- and O-glycans. The sugar part of IgA
depends on the origin, meaning the systemic and mucosal
immune systems [23, 24], and ranges from 6 % for serum
IgA up to 25 % for secretory component (SC) [22, 25, 26].
IgA1, IgA2 and SIgA may carry distinct populations of N-
and/or O-glycan structures, in part as the result of different
glycosylation machinery for epithelial and plasma cells [22,
25–27]. Royle et al. [25] have reported that a secretory
component of colostrum SIgA contains α1,4-, α1,3-, and
α1,2- fucosylated and α2,3-sialylated glycans that are
decoys for pathogens binding to mucosal surfaces. The
glycosylation pattern of amniotic IgA during the pregnancy
has not yet been elucidated and thus is of major interest
since it is associated with different origins and functions.
In our study, we analyze the alternations in the expression
of MAA- and SNA-reactive glycotopes and LCA-, LTA-,
and UEA-reactive glycotopes of IgA in amniotic fluid dur-
ing the normal human pregnancy from the 2nd trimester,
throughout the 3rd trimester, perinatal period, post-date
pregnancy and delivery. The levels of sialylation and fuco-
sylation of the IgA were determined by lectin-IgA-ELISA
using lectins with known specificity toward different types
of sialic acid and fucose linkages Table 1 [28–32]. The
sialylation and fucosylation patterns were determined on
plasma and amniotic IgA, isolated by modified polyclonal
anti-α chain antibodies. It should be pointed out that this
approach did not determine the ‘true’ structure of the human
IgA glycans, but allowed to observe the changes of glyco-
tope expressions accessible to the interactions with lectins.
Such glycan-lectin interactions between the lectin-receptors
and the sialyl- and fucosyl-glycotopes are emerging as key
elements in a wide range of pathophysiological processes.
Materials and methods
Patients and sampling
Samples of amniotic fluid (101) and blood plasma (101)
were obtained from pregnant women (21–38 years old) with




Maackia amurensis (MAA) Terminal sialic acid linked α2-3 to
Gal of N- and O-glycans [28]
Sambucus nigra (SNA) Terminal sialic acid linked α2-6 to Gal/
GalNAc of N- and O-glycans [29]
Lens culinaris (LCA) Fucose linked α1-6 to proximal
GlcNAc of the trimannosyl core
of biantennary N-glycans [30]
Tetragonolobus
purpureus (LTA)
Fucose linked α1-3 to GlcNAc
(in Lewisx) of N- and O-glycans [31]
Ulex europaeus (UEA) Fucose linked α1,2 to Gal
< Fucα1-2Galβ1,
<Fucα1-3 or 1-4GlcNAc
(in Lewisx or Lewisy) of N- and
O-glycans [32]
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gestational age between 14 and 42 weeks, receiving prenatal
care at the Department of Obstetrics and Gynaecology, Wro-
claw Medical University, Wrocław, Poland. During the 2nd
and 3rd trimesters, the amniotic fluid was taken by trans-
abdominal amniocentesis under ultrasonographic guidance,
and during delivery by transvaginal amniotomy. The samples
used for the current study consisted of the fluid remaining
after the performance of the routine diagnostic procedures. At
14–18 weeks of gestation, amniotic fluid was obtained by
amniocentesis for fetal karyotyping. In all cases, an accurate
gestational dating was established by obtaining knowledge
about the most recent menstrual period and confirmed by the
ultrasonographic evaluation. There were no signs of inflam-
mation, vaginal infection, or chorioamnionitis. All samples
were collected after the informed consent of the individual
women, and the study was approved by the local ethics
committee (no. KB-479/2006). Immediately after amnio-
centesis, all amniotic fluid samples were centrifuged at
3000xg for 20 min to separate cells from the superna-
tant, and then aliquoted and stored at −76 °C until use. The
frozen samples were thawed at 20 °C before use. Amniotic
fluid samples contaminated with blood or meconium were
discarded.
The samples of amniotic fluid and plasma were divided
into the following groups:
1) The second trimester, n021: 14–18 weeks of
pregnancy;
2) The third trimester, n012: 35–37 weeks of pregnancy;
3) Perinatal period, n011: 38–40 weeks of pregnancy;
4) Delivery, n040: 38–42 weeks of pregnancy. Fetuses
were delivered by spontaneous vaginal delivery within
3 h; and
5) Post-date pregnancy, n017: 41–42 weeks of pregnancy.
This group comprised of nine pregnancies terminated by
cesarean section and seven pregnancies by spontaneous
vaginal delivery lasting from 61 h to 200 h.
All women were healthy and delivered healthy newborns
without malformations, chromosomal abnormalities, and
postmaturity syndrome.
Additionally, plasma samples from healthy non-pregnant
women (n015) were included in the study.
Determination of immunoglobulin A concentration
Concentrations of IgA in the amniotic fluid and plasma
samples were determined by conventional ELISA. In short,
Maxisorp flat-bottomed 96-well microplates (NUNC, Ros-
kilde, Denmark) were coated for 2 h at 37 °C, and overnight
at 4 °C with 100 μl of 0.05 M carbonate/bicarbonate buffer
(pH 9.6) containing 3 μg/ml of polyclonal rabbit IgA isotype-
specific antibodies (DAKO, Glostrup, Denmark). After block-
ing with 1 % bovine serum albumin (BSA) (SERVA,
Heidelberg, Germany), 100 μl of twofold serial dilutions of
women’s plasma (range 1:10000–1: 80000), amniotic fluid
(range 1:100–1:800), or IgA standard (range 0.0078–0.5 μg/
ml) (Jackson Immunoresearch) in phosphate-buffered saline
with 0.05 % Tween 20 (PBS-T) containing 1 % BSA, were
added to each well and incubated for 2 h at 37 °C. After the
washing step, 100 μl of horseradish peroxidase-conjugated
rabbit antibodies diluted 1:4000 in PBS-T-1 % BSA were
added to each well, and plates were incubated for 2 h at 37 °
C. After washing, 100 μl of substrate solution containing
ortho-phenylenodiamine (Calbiochem, Denmark) in 0.1 M
citrate buffer, pH4.9 with H2O2 was added, and plates were
incubated for 20 min at room temperature in the dark. The
reaction was stopped with 1 M H2SO4, and optical
density was read at λ0490 nm with a Dynatech MR 5000
photometric reader (DYNATECH, Dynex Technologies, Sul-
lyfield Circle Chantilly, VA, USA).
Lectin-IgA-ELISA for differentiating
sialyl- and fucosyl-glycovariants
Glycotope expressions on IgA were determined by lectin-
IgA-ELISA, in accordance with the procedure described
earlier, slightly modified, [14, 33] using specific biotiny-
lated lectins [34] (Vector Laboratories Inc., Burlingame,
USA): Maackia amurensis lectin (MAA) [28] and Sambucus
nigra lectin (SNA) [29] with binding preferences to sialic acid
linked by anomeric glycosidic α2,3 and α2,6 linkages and
Lens culinaris lectin (LCA) [30], Tetragonolobus purpureus
lectin (LTA) [31], and Ulex europaeus lectin (UEA) [32]
showing binding preferences to fucose linked by anomeric
glycosidic linkages α1,6, α1,3, and α1,2, respectively. How-
ever, the binding specificity of lectins is not absolute and
usually covers a range of ligands with different relative affin-
ities. Binding will therefore vary depending on the abundance
and clustering patterns.
The experimental details of lectin-IgA-ELISA are as
follows: rabbit specific anti-human IgA polyclonal antibod-
ies (DAKO, Glostrup, Denmark), defucosylated and desia-
lylated by oxidation with sodium periodate and further
desialylated with Vibrio cholera neuraminidase, were dilut-
ed 1:1000 in 10 mM TRIS-buffered saline (TBS), pH8.5,
coupled to a polystyrene microtitre ELISA plate, and used to
extract and specifically bind IgA in the sample. For testing
purposes, 100 μl of amniotic fluid or blood plasma samples,
prediluted in 10 mM TBS pH7.5 containing 0.05 % Tween
20 to a final IgA concentration of 0.5 mg/l, were taken. The
presence of the respective sialyl-glycotopes and fucosyl-
glycotopes on IgA was detected by the reaction with the
specific biotinylated lectins MAA (1:500) or SNA (1:20
000) and LCA (1:500), LTA (1:500), or UEA (1:500),
respectively. The IgA-lectin complex was measured with
phosphatase-labeled ExtrAvidin (1:20 000) (Sigma, St.
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Louis, MO, USA), and then detected by the reaction with
disodium 4-nitrophenyl phosphate (Merck, Darmstadt, Ger-
many). The absorbance (AU) was measured in a Stat Fax
2100 Microplate Reader (Awareness Technology INC,
USA) at 405 nm with the reference filter at 630 nm.
Obtained absorbance values are proportional to the relative
amounts/expressions of fucosyl- and sialyl-glycotopes of
IgA.
All samples were analyzed in duplicate. The positive
control for MAA, SNA, LCA, LTA, and UEA was native
haptoglobin and asialo-haptoglobin preparations derived
from ovarian cancer fluid [35]. The negative control
was a human albumin preparation included in the test
instead of the amniotic fluid and plasma samples. The
background absorbance was low (0.05±0.02 AU) when TBS
was included in the tests instead of (1) lectin and (2)
ExtrAvidin-AP.
Statistical analysis
The statistical analysis was performed with STATISTICA
10 (StatSoft, Inc., Tulsa, USA). The Kruskal–Wallis test and
the Mann–Whitney U test were used for statistical signifi-
cance. The results were shown as the mean ± SD. The
correlations were estimated according to Spearman. A




The mean values of IgA concentration in the amniotic fluid
(Table 2) and plasma of pregnant women (Table 3) showed
no significant differences between the 2nd trimester, the 3rd
trimester, perinatal period, delivery, and post-date pregnan-
cy groups. The calculated mean and median values of IgA in
all plasmas of pregnant women (1.9±1.2 g/l and 1.8 g/l,
respectively), corresponded to the normal range of IgA
concentration in non-pregnant women (2.1±1.3 g/l and
1.9 g/l, respectively), and were nearly 1000-times higher
than in the amniotic fluids (7.7±4.4 mg/l and 6.5 mg/l,
respectively).
Table 2 Relative amounts of amniotic fucosyl- and sialyl-IgA glycoforms during normal pregnancy
No Groups and number
of samples
IgA mg/l Amniotic IgA reactivity (AU) with lectins
SNA MAA LCA LTA UEA
Specific to sialic acid attached by the linkages: Specific to fucose attached by the linkages:
α2-6 α2-3 α1-6 α1-3 α1-2
1. 2nd trimester
14–18 weeks 8.53±2.8 0.66±0.3 0.48±0.3 1.04±0.3 0.16±0.1 0.24±0.3
n021
2. 3rd trimester
35–37 weeks 6.86±3.6 1.18±0.5 1.5±0.5 1.11±0.4 0.54±0.4 1.05±0.7
n012 ap<0.001 ap<0.00004 ap<0.002 ap<0.0006
3. Perinatal period
38–40 weeks 6.97±4.0 1.15±0.5 1.68±0.4 1.01±0.4 0.42±0.4 1.0±0.8
n011
4. Delivery at
38–42 weeks 8.27±4.9 1.06±0.6 1.4±0.6 0.98±0.4 0.41±0.4 0.75±0.8
n040
5. Post-date pregnancy
41–42 weeks 6.68±4.3 1.42±0.4 1.69±0.3 1.24±0.3 0.6±0.3 1.07±0.6
n017 bp<0.03 bp<0.01 bp<0.009 bp<0.03
Values are given as the mean ± SD
The reactivity of 50 ng of IgA with MAA (Maackia amurensis lectin specific to α2,3-linked sialic acid), SNA (Sambucus nigra lectin specific
to α2-6-linked sialic acid), LCA (Lens culinaris lectin specific to α1,6-linked fucose), LTA (Tetragonolobus purpureus lectin specific to α1-3-
linked fucose), and UEA (Ulex europaeus lectin specific to α1,2-linked fucose) are expressed as the absolute value of absorbance (AU) at
405 nm based on the IgA-lectin immunoenzymatic assay as described in Materials and Methods
The Mann-Whitney U test and the Kruskal-Wallis test were used to calculate statistical differences between successive periods of pregnancy
A p-value less than 0.05 was considered significant. Significantly different from: a the 2nd trimester, b the delivery
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Expression of MAA- and SNA-reactive glycotopes
The amniotic fluid IgA of all samples reacted with SNA and
MAA indicating that the IgA glycans were potentially termi-
nated with sialic acid linked by the α2,6 or α2,3 glycosidic
bonds, respectively (Table 2). The expression of MAA-
reactive glycotope on IgA showed weak positive correlation
(r00.35) with the age of normal pregnancy, but no correlation
was found for SNA-reactive glycotope (r00.2).
The relative reactivity of amniotic IgAwith SNA (specific
to α2,6-sialyl-glycoform) and MAA (specific to α2,3-sialyl-
glycoform) was significantly lower (p<0.001 and p<0.00004,
respectively) in the 2nd trimester group (0.66±0.3 AU and
0.48±0.3 AU, respectively) than in the 3rd trimester (1.18±
0.5 AU and 1.50±0.5 AU, respectively). In the perinatal
period (1.15±0.5 AU and 1.68±0.4 AU, respectively) and
delivery (1.06±0.6 AU and 1.4±0.6 AU, respectively)
groups, the sialylation were nearly at the same levels as in
the 3rd trimester, however, α2,6-sialylation level became
significantly higher in the post-date pregnancy group (1.42±
0.4 AU; p<0.03) (Fig. 1).
The relative reactivity of plasma IgA of pregnant women
with SNA (~0.22 AU) had not changed during the stages of
pregnancy (Table 3) and was similar to that of non-pregnant
women group (0.23±0.04), however being significantly
lower (p<0.00001) when compared to that of amniotic
IgA reactivity. In contrast to amniotic IgA, none of plasma
IgA showed the reactivity with MAA (Table 2).
Expression of LCA-, LTA-, and UEA-reactive glycotopes
The amniotic IgA reactivity with LTA (specific to α1,3-
linked fucose), UEA (specific to α1,2-linked fucose) and
LCA (specific to α1,6-linked fucose) showed no correlation
with the age of normal pregnancy (r00.16; r00.17 and r0
0.02, respectively). In contrast, the expressions of all types
of fucosylated glycotopes showed strong or very strong
positive correlations (r00.68 for UEA and LTA; r0
0.61 for UEA and LCA; r00.89 for LCA and LTA,
respectively).
The amniotic fluid IgA from the 2nd trimester showed
relatively high reactivity with LCA (for α1,6-fucose) and
reacted slightly with LTA (for α1,3-linked fucose) and UEA
(for α1,2-fucose) (Table 2). The reactivity of amniotic IgA
with LCA remained nearly at the same level during the 2nd
trimester (1.04±0.3 AU), 3rd trimester (1.11±0.4 AU), the
Table 3 Relative amounts of plasma fucosyl- and sialyl-IgA glycoforms during normal pregnancy
No Groups and number
of samples
IgA g/l Plasma IgA reactivity (AU) with lectins
SNA MAA LCA LTA UEA
Specific to sialic acid attached by the linkages: Specific to fucose attached by the linkages:
α2-6 α2-3 α1-6 α1-3 α1-2
1. 2nd trimester
14–18 weeks 1.9±1.4 0.22±0.03 0.00 0.34±0.09 0.00 0.00
n021
2. 3rd trimester
35–37 weeks 2.0±1.1 0.22±0.04 0.00 0.31±0.08 0.00 0.00
n012
3. Perinatal period
38–40 weeks 1.8±0.8 0.21±0.02 0.00 0.31±0.06 0.00 0.00
n011
4. Delivery at
38–42 weeks 1.8±1.4 0.22±0.04 0.00 0.33±0.08 0.00 0.00
n040
5. Post-date pregnancy
41–42 weeks 2.0±1.2 0.21±0.03 0.00 0.33±0.09 0.00 0.00
n017
6. Non-pregnant women 2.1±1.3 0.23±0.04 0.00 0.31±0.06 0.00 0.00
n015
Values are given as the mean ± SD
The reactivity of 50 ng of IgAwith the respective lectin (for experimental details, see Table 1) is expressed as the absolute value of absorbance (AU)
at 405 nm based on the IgA-lectin immunoenzymatic assay as described in Materials and Methods
The Mann-Whitney U test and the Kruskal-Wallis test were used for statistical calculations. A p-value less than 0.05 was considered significant.
The mean values did not shown any significant differences between groups
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perinatal period (1.01±0.4 AU), and delivery (0.98±
0.4 AU). In contrast, the reactivity with LCA increased in
the post-date pregnancy (1.24±0.3 AU; p<0.01). The sig-
nificant increase of reactivity of amniotic IgAwith LTA and
UEA appeared in the 3rd trimester of pregnancy and
remained nearly at the same level from the 3rd trimester
(0.54±0.4 AU for LTA and 1.05±0.7 AU for UEA)
throughout the perinatal period (0.42±0.4 AU for LTA and
1.0±0.8 AU for UEA) to the delivery (0.41±0.4 AU for
LTA and 0.75±0.8 AU for UEA), though significantly
increased in the post-date pregnancy (0.6±0.3 AU; p<
0.009 for LTA and 1.07±0.6 AU; p<0.03 for UEA)
(Fig. 2).
The relative amount of LCA-reactive glycotope of plas-
ma IgA (Table 3) was at almost unchanged level throughout
pregnancy of 14–42 weeks including the delivery group,
and was three times lower when compared to amniotic
IgA reactivity with LCA (p<0.00001). Plasma IgA lacked
reactivity with α1-3- as well as α1-2-linked fucose specific
lectins (LTA and UEA, respectively).
Discussion
Our results indicate that despite the almost unaltered concen-
tration of IgA in amniotic fluid and pregnant women plasma,
Fig. 1 Reactivity of amniotic
fluid IgA with sialic acid-
specific lectins in relation to
pregnancy age. (a) with
Maackia amurensis lectin; (b)
with Sambucus nigra lectin. For
experimental details, see Ta-
ble 1. Box and whisker plots:
the bottom and top of the box
are the 25th and 75th percentile
(the lower and upper quartiles,
respectively), and the small box
near the middle of the box is the
median (the 50th percentile).
The ends of the whiskers repre-
sent the minimum and maxi-
mum of all the data
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Fig. 2 Reactivity of amniotic
fluid IgA with fucose-specific
lectins in relation to pregnancy
age. (a) with Lens culinaris
lectin; (b) with Tetragonolobus
purpureus lectin; (c) with Ulex
europaeus lectin. For experi-
mental details, see Table 1. Box
and whisker plots: the bottom
and top of the box are the 25th
and 75th percentile (the lower
and upper quartiles, respective-
ly), and the small box near the
middle of the box is the median
(the 50th percentile). The ends
of the whiskers represent the
minimum and maximum
of all the data
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the degree of the relative sialylation and fucosylation of the
amniotic IgA was connected with progression of the normal
pregnancy.
Amniotic fluid might be considered a precursor of human
milk feedings as an exogenous source of immunological
factors that protect the infant directly and shape the
responses of the infant’s own immune system. Thus, the
amniotic fluid being produced by, or at least transferred
across, epithelial surfaces and bathes many of the mucosal
surfaces of the fetus, might be considered part of the muco-
sal immune system [17]. Amniotic IgA might function as an
“antiseptic coating” at the mucosal surface by preventing a
bacterial adherence and an invasion of microorganisms [24].
In the amniotic fluid there is more than one source of IgA,
namely maternal plasma, decidua and fetus. Maternal IgA is
actively transported into the amniotic fluid and can be produced
locally in the decidua, since Cederqvist et al. [36] reported that
up to one-half of the IgA in amniotic fluid from 11 to 40 weeks
of gestation was of the IgA2, characteristic for produced by
mucosa [17]. The extent to which nonspecific diffusion and
receptor-mediated transport of maternal IgA and the fetal muco-
sa contributes to amniotic IgAvary with gestational age [17, 19].
In the 2nd trimester of normal pregnancy the amniotic
IgA showed a different pattern of sialylation and fucosyla-
tion than the plasma of pregnant women (Tables 2 and 3).
The amniotic IgAwas more highly LCA- and SNA- reactive
than the maternal IgA, suggesting that amniotic IgA was
heavily α2,6-sialylated and α1,6-fucosylated. Additionally,
the amniotic IgAwas decorated by glycotopes reactive with
MAA, LTA, and UEA. The appearance of the α2,3-sialylated
glycotope on glycoproteins recognized by MAAwas reported
by Hampel et al. [37] to be bound with fetal development and
classified as a fetal type of protein glycosylation. On the other
hand, the plasma IgA of both pregnant and non-pregnant
women did not show any reactivity with MAA (Table 3) and
that observation shows a discrepancy with findings of Mae-
numa et al. [38]. They have reported a reactivity of mutated
α2,3-sialic acid-specific MAA with IgA O-glycans isolated
from normal and IgA nephritis patients. It should be pointed
out that in our lectin-based analysis, the lack of reactivity of
the plasma IgA samples with MAA might result from a
different spatial accessibility of α2,3-sialylated glycotopes
hidden in the structure of the hinge region of native IgA [26,
27, reviewed 39] of plasma sample compared to the isolated
molecule of IgA. Moreover, the limited amount of native
plasma and amniotic fluid IgA, namely 50 ng, used in our
Lectin-ELISA probably also had impact on the observed lack
of reactivity.
During the 3rd trimester, the last immunological phase of
pregnancy, the fetus has completed its development; all the
organs are functional and ready to deal with the external
world [40]. Placental function is dynamic and influenced by
maternal health, and has an important regulatory role in
maternal and fetal well-being [41]. The glycosylation pattern
of amniotic IgA seems to be a net result of maternal, fetal, and
placental synthesis. Fetal urine is a major source, however,
Goldblum and Hilton [17] suggest that the IgA is produced
locally and excreted from the mucosal surfaces (other than
urinary tract) of the fetus, namely respiratory, saliva and
nasal secretions of fetus also contribute to the content of the
amniotic fluid.
The presence of highly MAA-, LTA-, and UEA-reactive
glycotopes at the turn of the 2nd and the 3rd trimesters is
probable connected with fetal development and maturation.
The fetus mucosal system production of IgA is increased
and outweighs the mother’s participation and has a direct
impact on the glycosylation pattern of amniotic IgA during
the 3rd trimester. The same characteristic quantitative switch
was previously observed for amniotic IgG [14] and other
amniotic glycoconjugates [42] and glycoproteins, namely
α1-acid glycoprotein [12] and fibronectin [43].
The expression of MAA-, SNA-, LCA-, LTA-, and UEA-
reactive glycotopes on amniotic IgA has only slightly changed
between the 3rd trimester and the perinatal period. Although
the data are for limited amount of samples because of rarely
occurring opportunities for the collection of amniotic fluid in
this period, they are very valuable to understand the protective
role of amniotic fluid. Moreover, the expression of LTA- and
UEA-reactive glycotopes (α1,3- and α1,2-fucosylated gly-
cans), which are known to create Lewis family determinants
[2], valuable indicators of inflammation [44, 45] as well as
molecules involved in innate immunity [25] may vary among
individuals as a result of a non-secretor status [46] of mother
and may reflect the sensitivity of individuals to external stim-
uli and efficiency of the immune system.
Delivery is characterized by an influx of immune cells
into the myometrium in order to promote recrudescence of
an inflammatory process. However, the proinflammatory
environment which promotes the contraction of the uterus,
expulsion of the baby, and rejection of the placenta [40, 47]
seems to have no impact on sialylation and fucosylation of
amniotic IgA during delivery. We have previously shown
that during the delivery amniotic IgG [14] and fibronectin
[43], glycoproteins which do not directly take part in response
to inflammation (characteristic for acute phase proteins),
also showed almost unaltered expression of fucosyl- and
sialyl-glycotopes.
Fetal and neonatal mortality rates increase sharply after
40 weeks of pregnancy [48]. The pregnancy can be pro-
longed by inadequate hormone levels and maternal obesity
and can increase the risk of Caesarean delivery and maternal
complications. Around 41 weeks placental function may
decline and become insufficient, reducing the supply of
oxygen and nutrients to the fetus [41, 48]. We have observed
that in the post-date pregnancy, there was the increase of the
fetal or/and placental origin of highly fucosylated and
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sialylated amniotic IgA glycoforms compared to those at
delivery. The changes observed by us for amniotic IgA in
the post-date pregnancy group, apart from MAA-reactive
glycotopes, overlap/correspond to those reported for the
amniotic IgG [14]. These findings can lead to the hypothesis
that for amniotic immunoglobulins a common gestational
age-dependent mechanism of glycosylation regulation can
exist, probably connected with site-dependent synthesis
and/or modulation of glycosylation.
In conclusion, pregnancy is a time of life where the
development, maturation of fetus, and modulation of the
immune system of mother, as well as differential responses
of diverse biological events may occur based on glycotope-
lectin receptor interactions. During the pregnancy stages these
interactions might be important for controlling the pro-
inflammatory and anti-inflammatory phases characterized by
the unique inflammatory environment reported by Mor et al.
[40]. In this aspect, the 1st and 3rd trimesters defined as
proinflammatory phases (Th1) are responsible for the implan-
tation and placentation as well as contraction of the uterus,
expulsion of the baby and rejection of the placenta, respec-
tively. On the contrary, the 2nd trimester represents an anti-
inflammatory phase, also known as the Th2 environment, in
which the mother, placenta and fetus are symbiotic [40, 49]. It
should be noted that the observed changes of the expressions
of lectin-reactive sialylated and fucosylated glycotopes at the
turn of the 2nd and the 3rd trimesters also overlap with
immunological phases of pregnancy (Fig. 3).
In our opinion, the pregnancy-associated unique expres-
sions of sialylated and fucosylated glycoforms of amniotic
IgA illustrate a general importance of carbohydrate-lectin
and/or carbohydrate-carbohydrate interactions in the control
and modulation of pro- and anti-inflammatory events to
ensuring the fetus well-being. Glycovariants of amniotic
IgA associated with pregnancy progression overlap and/or
are influenced by a gestational-depended pro- and anti-
inflammatory condition. They seem to be molecular indica-
tors reflecting the pregnancy age and can also be used as a
window into the physiological events that lead up to both
normal and post-date pregnancy. However, a future aim for
these studies is the structural analysis of the IgA oligosac-
charides that should confirm or verify relative levels of sialic
acid and fucose of the lectin based proposals, and helps to
understand their role and impact on the course of pregnancy.
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reproduction in any medium, provided the original author(s) and the
source are credited.
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